Skip to main content
. 2019 Jul-Aug;94(4):434–441. doi: 10.1590/abd1806-4841.20198250

Table 2.

LGI3 immunohistochemical staining of vitiligo patients before and after phototherapy, and controls

Immunohistochemical staining Studied group (N=60) Test of Significance p-value
  Controls n=20 Cases before treatment n=40 Cases after treatment n=40    
Expression NO % NO % NO % T1=χ2=8.29 P1=0.003*
Positive 20 100 27 67.5 37 92.5 T2=Mc Nemar χ2=10.58  P2=0.001*
Negative 0 0.0 13 32.5 3 7.5 T3= χ2=1.85 P3=0.554
Localization                
Cytoplasmic 18 90 24 88.9 31 83.8 T1= χ2=0.83 P1=0.659
Membranous 0 0 1 3.7 1 2.7 T2=MH=0.447 P2=0.655
Membrano-cytoplasmic 2 10 2 7.4 5 13.5 T3= χ2=0.73 P3=0.694
Intensity                
Mild 10 50.0 22 81.5 18 48.6 T1= χ2=8.65 P1=0.013*
Moderate 5 25.0 5 18.5 14 37.8 T2=MH=2.99 P2=0.003*
Strong 5 25.0 0 0.0 5 13.5 T3= χ21.62 P3=0.444
Distribution             T1= χ2=0.366 P1=0.545
Patchy 14 70.0 21 77.8 20 54.05 T2=Mc Nemar χ2=6.50 P2=0.011*
Diffuse 6 30.0 6 22.2 17 45.9 T3= χ2=1.37 P3=0.242
Percentage                
Mean ± SD 40.25±26.83   18.22±18.44   39.07±24.89   T1=U=116.00 P1=0.001*
Range 10.0-85.0   2.0-70.0   2.0-95.0   T2=Wilcoxon signed rank=4.29 P2=0.001*
Median 30.0   10.0   30.0   T3=U=0.528 P3=0.597
H score                
Mean ± SD 89.75±94.79   25.26±31.03   74.11±71.96   T1=U=3.39 P1=0.001*
Range 10.0-255.0   2.0-120.0   2.0-240.0   T2=Wilcoxon signed rank =4.38 P2=0.001*
Median 40.0   10.0   45.0   T3=U=0.570 P3=0.569

T1: test of significance for comparison between cases before treatment and controls; T2: test of significance for comparison between cases before and after treatment; T3: test of significance for comparison between cases after treatment and controls; P1: p-value of comparison between cases before treatment and controls; P2: p-value of comparison between cases before and after treatment; P3: p-value of comparison between cases after treatment and controls;

*

Significant.